These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17474732)

  • 1. Isoform-selective inhibition of the human UDP-glucuronosyltransferase 2B7 by isolongifolol derivatives.
    Bichlmaier I; Kurkela M; Joshi T; Siiskonen A; Rüffer T; Lang H; Suchanova B; Vahermo M; Finel M; Yli-Kauhaluoma J
    J Med Chem; 2007 May; 50(11):2655-64. PubMed ID: 17474732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inhibitors of the human UDP-glucuronosyltransferase 2B7 derived from the sesquiterpenoid alcohol longifolol.
    Bichlmaier I; Kurkela M; Joshi T; Siiskonen A; Rüffer T; Lang H; Finel M; Yli-Kauhaluoma J
    ChemMedChem; 2007 Jun; 2(6):881-9. PubMed ID: 17479992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eudismic analysis of tricyclic sesquiterpenoid alcohols: lead structures for the design of potent inhibitors of the human UDP-glucuronosyltransferase 2B7.
    Bichlmaier I; Kurkela M; Siiskonen A; Finel M; Yli-Kauhaluoma J
    Bioorg Chem; 2007 Oct; 35(5):386-400. PubMed ID: 17706742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereochemical and steric control of the UDP-glucuronosyltransferase-catalyzed conjugation reaction: a rational approach for the design of inhibitors for the human UGT2B7.
    Bichlmaier I; Finel M; Sippl W; Yli-Kauhaluoma J
    ChemMedChem; 2007 Dec; 2(12):1730-40. PubMed ID: 17943712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms.
    Sakaguchi K; Green M; Stock N; Reger TS; Zunic J; King C
    Arch Biochem Biophys; 2004 Apr; 424(2):219-25. PubMed ID: 15047194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases.
    Court MH
    Methods Enzymol; 2005; 400():104-16. PubMed ID: 16399346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.
    Picard N; Ratanasavanh D; Prémaud A; Le Meur Y; Marquet P
    Drug Metab Dispos; 2005 Jan; 33(1):139-46. PubMed ID: 15470161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple pharmacophores for the investigation of human UDP-glucuronosyltransferase isoform substrate selectivity.
    Sorich MJ; Miners JO; McKinnon RA; Smith PA
    Mol Pharmacol; 2004 Feb; 65(2):301-8. PubMed ID: 14742671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral distinction between the enantiomers of bicyclic alcohols by UDP-glucuronosyltransferases 2B7 and 2B17.
    Bichlmaier I; Siiskonen A; Kurkela M; Finel M; Yli-Kauhaluoma J
    Biol Chem; 2006 Apr; 387(4):407-16. PubMed ID: 16606339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver.
    Mano Y; Usui T; Kamimura H
    Drug Metab Dispos; 2007 Nov; 35(11):2040-4. PubMed ID: 17670842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation.
    Lewis BC; Mackenzie PI; Elliot DJ; Burchell B; Bhasker CR; Miners JO
    Biochem Pharmacol; 2007 May; 73(9):1463-73. PubMed ID: 17223084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
    Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
    Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiral Inhibition of Rivaroxaban Derivatives Towards UDP-Glucuronosyltransferase (UGT) Isoforms.
    Yao Z; Liu YZ; Ma AL; Wang SF; Lu D; Hu CM; Zhang YY; Wang H; Hu L; Deng J; Yang K; Fang ZZ
    Chirality; 2015 Dec; 27(12):936-43. PubMed ID: 26425918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.
    Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO
    Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory potential of chlormadinone acetate (CMA) on five important UDP-glucuronosyltransferases in human liver.
    Huang T; Fang ZZ; Zhang YY; Zhu LL; Feng LL; Zheng W; Cao YF; Sun DX; Yang L
    Pharmazie; 2011 Mar; 66(3):212-5. PubMed ID: 21553653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of catechols by recombinant human sulfotransferases, UDP-glucuronosyltransferases, and soluble catechol O-methyltransferase: structure-conjugation relationships and predictive models.
    Taskinen J; Ethell BT; Pihlavisto P; Hood AM; Burchell B; Coughtrie MW
    Drug Metab Dispos; 2003 Sep; 31(9):1187-97. PubMed ID: 12920175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong inhibitory effect of medroxyprogesterone acetate (MPA) on UDP-glucuronosyltransferase (UGT) 2B7 might induce drug-drug interactions.
    Huang T; Fang ZZ; Yang L
    Pharmazie; 2010 Dec; 65(12):919-21. PubMed ID: 21284263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families.
    Radominska-Pandya A; Bratton SM; Redinbo MR; Miley MJ
    Drug Metab Rev; 2010 Feb; 42(1):133-44. PubMed ID: 19821783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.